ORLANDO, Fla., May 8 /PRNewswire-FirstCall/ -- The following is being issued by Telzuit Medical Technologies, Inc.:
WHAT: Consumer Interest Reporter, Mike Holfeld was given exclusive, behind-the-scenes access to Telzuit Medical Technologies’ wireless heart monitoring network in Orlando. WHEN: Available online now! Originally aired on Friday, April 28, 2006 during WKMG/CBS-TV’s top-rated newscast. WHY: Get an in-depth look at the vision and technology behind Telzuit’s signature mobile cardiac monitoring device. Physicians will soon be prescribing this revolutionary Holter monitor that will allow cardiac patients to comfortably proceed with daily activities while their EKG data is sent to the Company’s monitoring center for real-time analysis. WHERE: http://www.telzuit.com (to view the a video clip of the segment go to Investor Relations, Press Releases, and click on the WKMG-Orlando press release dated 4/28/06) WHO: Jim Tolan, Co-founder of Telzuit Medical Technologies, Dr. Ronald Breinger, local physician, and Dr. Ronald Berger of the Johns Hopkins Hospital are interviewed. About Telzuit Medical Technologies, Inc.
Telzuit Medical Technologies, Inc. is dedicated to providing advanced mobile medicine for people worldwide. The company is in the final stages of launching its first product, the FDA-approved Bio-Patch Wireless Heart Monitor. The Bio-Patch is a full 12-lead, completely wireless Holter monitor, which is new to the marketplace. In conjunction with its strategic partners, Telzuit is also building its own dedicated intranet platform to handle several of the products it will be releasing, including the Bio-Patch. Telzuit is based in Orlando, Florida. For more information on Telzuit, its business model, and its products, please visit the company’s website: http://www.telzuit.com.
Forward Looking Statement: Except for factual statements made herein, the information contained in this press release consists of forward-looking statements that involve risks and uncertainties, including the effect of changing economic conditions, competition within the health products industry, customer acceptance of products, and other risks and uncertainties. Such forward-looking statements are not guarantees of performance, and Telzuit’s results could differ materially from those contained in such statements. These forward-looking statements speak only as of the date of this release, and Telzuit undertakes no obligation to publicly update any forward-looking statements to reflect new information, events or circumstances after the date of this release.
Contact: For Telzuit Medical Technologies, Inc. James Tolan Co-Founder 407-354-1222 Brainerd Communicators, Inc. Jennifer Gery (media) Todd St.Onge (investors) 212-986-6667
Telzuit Medical Technologies, Inc.
CONTACT: James Tolan, Co-Founder of Telzuit Medical Technologies, Inc.,+1-407-354-1222; or Media: Jennifer Gery, or Investors: Todd St.Onge, bothof Brainerd Communicators, Inc., for Telzuit Medical Technologies, Inc.
Web site: http://www.telzuit.com/